In the March quarter (Q4FY26), NLC India reported a 189 per cent increase in net profit to ₹1,393.46 crore, as compared to ₹481.96 crore a year ago.
Nomura has maintained a 'Buy' on Titan with an unchanged target price of ₹4,950, based on 60x March 2028 earnings per share (EPS)
Stock picks: Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma, Tata Steel & Sona BLW; here's why
Stocks to buy today: Jatin Gedia of Teji Mandi Investment Technologies suggests buying NTPC Green, Balrampur Chini and trent; check target
The buying on the counter came after Parag Milk Foods entered India's growing ready-to-drink (RTD) protein beverage market under its sports nutrition brand Avvatar
In the March quarter (Q4FY26), Heritage Foods reported a net profit of ₹23.9 crore, as compared to ₹38.2 crore, down 37 per cent Y-o-Y
The buying on the counter came after Satin Creditcare Network reported its Q4FY26 numbers on Monday, after market hours
Groww block deal: According to Bloomberg data, 319.3 million shares or 5.1 per cent of equity were traded in multiple block deals
In the March quarter (Q4FY26), Fractal Analytics reported a net profit of ₹117.8 crore, as compared ₹54.8 crore a year ago
Anand James of Geojit Investments has recommended these three mid-and-smallcap stocks to buy today; check target and other details
Motilal Oswal sector of the week: TVS Motor's long-term growth is driven by consistent market share gains across domestic and export markets, strong product portfolio and expanding EV presence
In the March quarter (Q4FY26), Affle 3I reported a net profit of ₹119.5 crore, as compared to a net loss of ₹103.1 crore in the same period last year
HSBC Global Investment Research has initiated coverage on PhysicsWallah with a 'Buy' rating and a target price of ₹135 per share
In the March quarter (Q4FY26), Urban Company reported a net loss widened to ₹161.16 crore, as compared to a net loss of ₹2.84 crore Y-o-Y
Niva Bupa reported net profit at ₹345.13 crore, as compared to ₹206.08 crore in the same period last year, up 67.4 per cent
In the March quarter (Q4FY26), Swiggy reported that its net loss narrowed to ₹800 crore, lower than the net loss of ₹1,081 crore Y-o-Y
Stocks to buy: Aakash Shah of Choice Broking suggests buying Apollo Hopsitals, Senores Pharma and one other stock; here's why
Sensex Today | Stock Market LIVE Updates Friday: The GIFT Nifty indicated that the Nifty50 will start the day on a negative note. Asian markets were trading in losses on renewed US-Iran tension
Brokerages tracked by Business Standard estimate Swiggy's net loss at an average of ₹857.56 crore year-on-year (Y-o-Y) from a loss of ₹971.66 crore
The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP